ArticleCurrent microbiology2025
Enhancing the Antimicrobial Effectiveness of Zinc Oxide Nanoparticles Against Staphylococcus aureus, Through Combination with Potassium and Zingerone.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Staphylococcus aureus (S. aureus) is a common cause of nosocomial infections, posing substantial public health challenges. The current study employed a synthesized zingerone-potassium-doped ZnO (Zin-K-ZnO) nanoparticles (NPs) against the growth and biofilm formation by S. aureus. A real-time PCR was used for assessment of the expression of antibiotic resistance and virulence factor (mecA and spA, respectively) in S. aureus under treatment with the NPs compared to control. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay was used to determine the cytotoxicity of the NPs based on the survival percentage of HCT-116 cells cultured with NPs of the concentration obtained for MIC. Structure analyses revealed that the NPs exhibited an approximately spherical morphology, with an average diameter of 37 nm. Antibacterial activity assessment demonstrated dose-dependent inhibition of S. aureus growth by the NPs. The minimum inhibitory concentration (MIC) of Zin-K-ZnO NPs (9.5 mM) was significantly lower than the value for zingerone (56 mM). Furthermore, Zin-K-ZnO NPs at the concentration of 64-1024 mg/mL prevented S. aureus biofilm formation by 19.9-81.0 ± 4.7%, which was significantly more effective compared to zingerone. Additionally, the NPs led to a substantial decrease in the expression of spA and mecA genes in S. aureus. MTT result revealed that NPs with the concentration of 9.5 mM had low cytotoxicity (92% cell viability) on HCT-116 cells. The results highlighted the strong antibacterial properties exhibited by both zingerone and Zin-K-ZnO NPs against S. aureus growth and biofilm formation.
Indexed as
Identifiers
40782168What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.